Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3772852 | 0.91 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL3775262 | 0.91 | SLC5A2 (0.56) | SLC5A2SLC5A1 | |
| SCHEMBL797556 | 0.91 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL797496 | 0.90 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL796791 | 0.89 | SLC5A2 (0.62) | SLC5A2SLC5A1 | |
| SCHEMBL3766942 | 0.89 | SLC5A2 (0.62) | SLC5A2SLC5A1 | |
| SCHEMBL12588984 | 0.88 | SLC5A2 (0.61) | SLC5A2SLC5A1 | |
| SCHEMBL13446116 | 0.85 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL12646410 | 0.85 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL12646294 | 0.84 | SLC5A2 (0.49) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7956041-B2 | antidiabetic mixture contains an inhibitor of renal glucose reabsorption and a hypoglycemic agent; controlling blood glucose level; tolbutamide, chlorpropamide, glibenclamide, glipizide, glimepiride, and gliclazide; metformin, phenformin and buformin; repaglinide, nateglinide and mitiglinide | AJINOMOTO CO., INC. (JP) | 2011-06-07 | — | — | US | disclosed |